Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Panelius, M"'
Autor:
Polman, C., Barkhof, F., Kappos, L., Pozzilli, C., Sandbrink, R., Dahlke, F., Jakobs, P., Lorenz, A., Hern, J., Coleman, R., Soelberg Srensen, P., Hartung, H. P., Fredrikson, S., Selmaj, K., Pelletier, J., D'Hooghe, M. B., Comi, G., Hohfeld, R., Gold, R., Panelius, M., Ruutiainen, J., Clanet, M., de Vos, M., Jonker, M., van Ijken, T., Jansen, E., van Schijndel, R., Karas, G., Wagner, K., Ghazi, M., Kurth, D., Sauerbrey, K., Tries, E., McFarland, H. F., Miller, D. H., Montalban, X., Petkau, J.
Publikováno v:
Polman, C, Barkhof, F, Kappos, L, Pozzilli, C, Sandbrink, R, Dahlke, F, Jakobs, P, Lorenz, A, Hern, J, Coleman, R, Soelberg Srensen, P, Hartung, H P, Fredrikson, S, Selmaj, K, Pelletier, J, D'Hooghe, M B, Comi, G, Hohfeld, R, Gold, R, Panelius, M, Ruutiainen, J, Clanet, M, de Vos, M, Jonker, M, van Ijken, T, Jansen, E, van Schijndel, R, Karas, G, Wagner, K, Ghazi, M, Kurth, D, Sauerbrey, K, Tries, E, McFarland, H F, Miller, D H, Montalban, X & Petkau, J 2003, ' Oral interferon beta-1a in relapsing-remitting multiple sclerosis: A double-blind randomized study ', Multiple Sclerosis, vol. 9, no. 4, pp. 342-348 . https://doi.org/10.1191/1352458503ms923oa
Multiple Sclerosis, 9(4), 342-348. SAGE Publications Ltd
Multiple Sclerosis, 9(4), 342-348. SAGE Publications Ltd
Background: Interferon beta (IFNB) is available in parenter al formulations for treatment of multiple sclerosis (MS). The purpo se of this study was to evaluate safety, tolerability and effects on MRI lesions of three different doses of oral IFNB-1a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aef624cdd9067be4b1ae629f1bdd85d
https://research.vumc.nl/en/publications/a8dc353e-7d8e-403e-b485-5c2fa35e0a2d
https://research.vumc.nl/en/publications/a8dc353e-7d8e-403e-b485-5c2fa35e0a2d
Autor:
Francis, G, Hughes, R, King, J, Mitchell, P, Joubert, J, McLeod, J, Parker, G, Pollard, J, Sindic, CJM, Duprez, T, Medaer, R, Broeckx, J, Vanroose, E, Carton, H, Wilms, G, Rice, G, Ebers, G, Lee, DH, Freedman, M, Nelson, R, Rabinovitch, H, Christie, S, Avruch, L, Oger, J, Paty, DW, Li, D, Wikstrom, J, Salonen, OLM, Panelius, M, Eralinna, J, Sonninen, P, Rieckmann, P, Hahn, D, Flachenecker, P, Hartung, HP, Uitdehaag, B, Bertelsmann, FW, Barkhof, F, Hommes, OR, Jongen, PJH, Van Doorn, PA, Tanghe, HLG, Sandberg-Wollheim, M, Larsson, EM, Lonntoft, M, Sallerfors, S, Kappos, L, Lienert, C, Radu, EW, Chofflon, M, Roth, S, Castillo, V, Schwieger, AF, Hughes, RAC, Clews, AM, Bingham, JB, Barnes, D, Clifton, AG, Stoy, N, Bates, D, Coulthard, A, Blumhardt, LD, Evans, SM, Jaspan, T, Palace, J, Newsom-Davis, JM, Byrne, JV, Quaghebeur, G, Li, DKB, Zhao, GJ, Riddehough, A, Rhodes, B, Grp, PRISMSS, Anal, UBCMSMRI
Publikováno v:
NEUROLOGY. 56(12)
Autor:
Ebers, GC, Rice, G, Lesaux, J, Paty, D, Oger, J, Li, DKB, Beall, S, Devonshire, V, Hashimoto, S, Hooge, J, Kastrukoff, L, Krieger, C, Mezei, M, Seland, P, Vorobeychi, G, Morrison, W, Nelson, J, Freedman, MS, Chrisie, S, Nelson, R, Rabinovitch, H, Freedman, C, Hartung, HP, Rieckmann, P, Archelos, J, Jung, S, Weilbach, F, Flachenecke, P, Sauer, J, Hommes, O, Jongen, P, Brouwer, S, McLeod, J, Pollard, J, Ng, R, Sandberg-Wollheim, M, Kallen, K, Nilsson, P, Ekberg, R, Lundgren, A, Jadback, G, Wikstrom, J, Multanen, J, Valjakka, M, Carton, H, Lissoir, F, Declerq, I, Vieren, M, Peeters, E, Dubois, B, Dekeersmaeker, E, Van Herle, A, Hughes, RAC, Sharrack, B, Soudain, S, Panelius, M, Eralinna, J, Soilu-Hanninen, M, Murto, S, Medaer, R, Broeckx, J, Vanroose, E, Bogaers, A, Blumhardt, LD, Edwards, S, Liu, C, Orpe, V, Barnes, D, Schwartz, M, Stoy, N, Harraghy, C, Bertelsmann, F, Uitdehaag, B, Nasseri, K, Chofflon, M, Roth, S, Kappos, L, Huber, S, Bellaiche, Y, Senn, C, King, J, Jubert, J, Whitten, S, Newsom-Davis, JM, Palace, J, Lee, M, Evangelou, N, Pinto, A, Cavey, A, Sindic, CJM, Monteyne, P, Verougstraete, D, Van Doorn, PA, Moll, W, Visser, L, Willems, M, Martina, I, Buljevac, D, Loman, L, Bates, D, Pandit, D, Irving, J, Rhodes, B, Riddehough, A, Zhao, GJ, Wang, X, Cheng, Y, Ammoury, N, Dupont, F, Galazka, A, Hyde, R, Olson, M, Pernin, MO, Abdul-Ahad, AK, Noseworthy, J, Borden, E, O'Brien, P, Wolinsky, J, Grp, PRISMSS
Publikováno v:
Lancet. 352(9139)
BACKGROUND: Previous trials of interferon beta in multiple sclerosis (MS) have shown efficacy, but the degree of clinical benefit remains uncertain, and the optimum dose is not known. We undertook a double-blind, placebo-controlled study in relapsing
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Neurologica Scandinavica; May1977, Vol. 55 Issue 4, p299-309, 11p
Publikováno v:
Acta Neurologica Scandinavica; Apr1974, Vol. 50 Issue 2, p183-193, 11p
Publikováno v:
Acta Oto-Laryngologica; 1988, Vol. 105 Issue S449, p77-83, 7p
Publikováno v:
Zeitschrift Für Neurologie; 1974, Vol. 206 Issue 4, p345-348, 4p
Publikováno v:
European Journal of Clinical Pharmacology; 1979, Vol. 15 Issue 6, p421-425, 5p